Top Analyst Hikes the Price Target on UnitedHealth Stock (UNH)
UnitedHealth Group (UNH) has had a tough year so far, with shares of the health insurance giant down around 39% year-to-date. The drop has been caused by several issues, including higher costs in its Medicare Advantage (MA) business, weak Q1 results, and a sudden CEO transition. Even so, UNH stock forecast received a price target hike from a 5-star analyst, Lisa Gill of JPMorgan. Gill lifted the price target on the stock to $418 from $405 yesterday, while maintaining her “Buy” rating. The revised price target implies about 36% upside potential from current levels.
Confident Investing Starts Here:
Analyst Sees Recovery Potential Despite Medicare Pressure
Gill’s updated outlook comes after a recent meeting with…
